baber/WOPTO huggingface dataset:
Patent AU-2004268441-B2 (AU)
Title: Surface treatment of the membrane and associated product
Inventor: MOACHON NICOLAS
IPC: A61M1/22
Filed: 2004-07-15
Granted: 2009-07-16
Abstract: A unit element forming a membrane comprising a semi-permeable material able to separate in two compartments a filtration device for extracorporeal treatment of fluid. The material is negatively charged and the element has a first internal face for direct contact with fluid under treatment and a second external face for contact with filtrate. The second face has a surface treated by a substance comprising at least a cationic polymer, or by a mixture of polymers of which at least one polymer is cationic. The unit element can also have a first face treated as the second face. The invention refers also to a semipermeable membrane comprising the unit elements, and to a filtration device comprising two compartments separated by such a semipermeable membrane, as well as to processes for manufacturing above components and devices.
Patent AU-2004281265-B2 (AU)
Title: Flexible film packaging having removable strip
Inventor: KOHL GARRETT WILLIAM
IPC: B32B37/15
Filed: 2004-09-21
Granted: 2009-05-28
Abstract: Slitters cut through a first layer of film immediately prior to lamination of the first layer to a second layer of film to form a strip therebetween. The degree of bonding between the first and second layers is adjusted so that the strip can be removed without harming the rest of the film or destroying any barrier properties. The lamination process can utilize extrusion lamination or adhesive lamination to provide a variety of uses: removable coupons, prize disclosures, stickers, and an adhesive re-close strip.
Patent AU-2005243962-B2 (AU)
Title: Polymer mixture consisting of an impact-resistance modified poly(meth)acrylate and a fluoropolymer
Inventor: DEUSCH NORBERT
IPC: C08L51/04
Filed: 2005-05-17
Granted: 2010-07-29
Abstract: The invention relates to a molded body consisting of plastic with a material thickness of at least 150 $g(m)m at any point. Said body contains a polymer mixture of an impact-resistance modified poly(meth)acrylate plastic, a polymethyl methacrylate matrix, elastomer particles contained in said matrix and a fluoropolymer. According to the invention, the fraction of the fluoropolymer in the mixture is between 30 and 95 wt. % and the polymer mixture of the impact-resistance modified poly(meth)acrylate plastic and the fluoropolymer is present in an outer layer with a continuous material thickness of at least 10 $g(m)m. The invention is characterized in that the impact-resistance modified poly(meth)acrylate plastic consists of between 20 and 70 wt. % poly(meth)acrylate matrix and between 30 and 80 wt. % elastomer particles.
Patent AU-2005244814-B2 (AU)
Title: Methods of treating disease with random copolymers
Inventor: KEITH JOHNSON
IPC: A61P25/00
Filed: 2005-05-09
Granted: 2011-09-15
Abstract: The invention relates to novel methods and kits for treating or preventing disease through the administration of random copolymers. The invention also relates to the treatment of autoimmune diseases, such as multiple sclerosis, and to the administration of random copolymers in treatment regimen comprising formulations that are administered at intervals greater than 24 hours, or to sustained release formulations which administer the copolymer over a period greater than 24 hours. The invention further relates to methods for conducting a pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the formulations or dosing regimens of random copolymer described herein.
Patent AU-2005270015-B2 (AU)
Title: Light guide for dentistry applications
Inventor: ROSE ERIC P
IPC: A61C1/00
Filed: 2005-06-30
Granted: 2011-09-29
Abstract: The present invention relates to a light guide for a lamp for dentistry procedures. The light guide provides an optical channel between a light source and a dental substrate. The light guide may be a one-patient use light guide including a recording medium to record the time used. The light guide further provides protection for a patient's soft tissues during treatment.
Patent AU-2005284748-B2 (AU)
Title: 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
Inventor: DEMAREST KEITH T
IPC: C07C323/20
Filed: 2005-09-14
Granted: 2011-09-29
Abstract: The invention features 4 ((phenoxyalkyl)thio) phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR modulators to treat or inhibit the progression of, for example, dyslipidemia
Patent AU-2006200128-B2 (AU)
Title: Baking device especially for self-service shops
Inventor: ROBERT OCHSENSHLAGER
IPC: A21B1/46
Filed: 2006-01-12
Granted: 2011-09-22
Abstract: The subject matter of the present invention is a baking device for especially self-service shops. This comprises an oven compartment (1) and a storage unit (2) for 5 unbaked products (B) positioned before the oven compartment (2). A dispensing unit (3) for ready-baked goods (F) positioned after the oven compartment (1) is further provided. A conveying device (4, 5, 6) ensures that the unbaked products (B) are conveyed from the storage unit (2) through the oven compartment (1) to the dispensing unit (3). According to the invention, a counting device (11) is additionally 10 provided which controls the conveying device (4, 5, 6) and/or the oven compartment (1) and/or the optional supply unit (7) for the unbaked products (B) such that a predetermined number of ready-baked goods (F) is supplied to the dispensing unit (3). 11/01/06,eh15470.spc,2
Patent AU-2006248558-B2 (AU)
Title: Multi-position support apparatus featuring a motorized foot support
Inventor: PAZ OHAD
IPC: A47K3/20
Filed: 2006-05-16
Granted: 2011-03-31
Abstract: Bathing systems and corresponding methods featuring a multi-position support apparatus. In one non-limiting embodiment, the multi-position support apparatus is accepting a user in a standing position, moving the user into a predefined reclining position, bathing the user in the predefined reclining position, and returning the user to a standing position.
Patent AU-2006264127-B2 (AU)
Title: Pre-filter for an ostomy bag
Inventor: BJARNE WORSOEE
IPC: A61F5/441
Filed: 2006-06-28
Granted: 2011-07-21
Abstract: An ostomy bag (10) with a filter assembly having a gas filter (18) and a pre-filter (14) for preventing or delaying solid/semisolid matter and liquid from reaching the gas filter. The pre-filter is at least substantially flat and comprises a number of constrictions (28) , such as ribs extending along and between two inner surface parts (24, 26) of the channel. These constrictions/ribs form narrower and wider passages where the gas may more quickly pass a narrow passage and where the wider passages tend to receive and hold the liquid, solid matter and semisolid matter. At least a part of the constrictions may be provided in a random pattern.
Patent AU-2006274821-B2 (AU)
Title: Pharmaceutical compositions comprising a tungsten salt (VI) for the treatment of neurodegenerative disorders, particularly Alzheimer's disease and schizophrenia
Inventor: JORGE DOMINGUEZ REYES
IPC: A61K33/24
Filed: 2006-07-28
Granted: 2011-10-13
Abstract: The invention relates to pharmaceutical compositions for the treatment of neurodegenerative disorders, comprising an effective quantity of a tungsten compound (VI), preferably a tungstate salt and more preferably sodium tungstate (NaWO). The inventive pharmaceutical compositions can be used for the prophylactic and/or therapeutic treatment of neurodegenerative disorders in mammals, including humans, and, in particular, for the prophylactic and/or therapeutic treatment of Alzheimer's disease and schizophrenia. The effect of sodium tungstate dihydrate in tau phosphorylation was assessed using a model of insulin-resistant mice and a Type 1 diabetes model. The therapeutic treatment of tauopathies that derive from said invention affords numerous advantages: GSK3 inhibition, specificity owing to a reduction in abnormal tau hyperphosphorylation caused by a specific neural protein, efficacy, absence of toxicity, and low price.
Patent AU-2006283687-B2 (AU)
Title: Progressive game and processing system thereof
Inventor: DOYLE THOMAS P
IPC: G06F19/00
Filed: 2006-08-16
Granted: 2012-04-26
Abstract: A progressive game is implemented on a gaming system, wherein the gaming system includes one or more gaming machines connected to a game server, and wherein the progressive game has a progressive prize value that increases according to a progressive prize growth rate. The progressive game includes a selectable targeted progressive prize value, a selectable targeted progressive prize time, and one or more enticement factors. The progressive prize growth rate is calculated using the selectable targeted progressive prize value, the selectable targeted progressive prize time, and the one or more enticement factors. Additionally, a random number generation algorithm tests to determine if there is a progressive prize win at each predetermined time period. The selectable targeted progressive prize time is used to calculate the predetermined time period for testing for a progressive prize win.
Patent AU-2006297304-B2 (AU)
Title: Method of identifying membrane LG specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells
Inventor: YOUNG JAMES F
IPC: C12N15/85
Filed: 2006-09-28
Granted: 2012-05-17
Abstract: The present invention relates to the discovery of antibodies that bind to novel epitopes present on membrane-anchored immunoglobulins and which bind to these novel epitopes on the surface of B cells and plasma cells. In addition, the antibodies of the present invention can mediate ADCC and can be useful to deplete those B cells and plasma cells expressing the novel epitopes of the invention. The antibodies of the present invention can be useful for the treatment of B cell -mediated diseases and diseases caused by monoclonal expansion of B cells. Accordingly the present invention also provides compositions and methods for the prevention, management, treatment or amelioration of B cell-mediated diseases and diseases caused by monoclonal expansion of B cells.
Patent AU-2006298559-B2 (AU)
Title: Pharmaceutical compositions stabilized in glassy particles
Inventor: BRUCE ROSER
IPC: A61K47/10
Filed: 2006-10-04
Granted: 2012-01-12
Abstract: Present proposals for liquid-medium carriers for glass particles comprising pharmaceutical compositions have had problems associated with aggregation of the glass particles. This has been previously solved by matching the density of the particles and a liquid in which they are suspended. However, though this greatly constrains the choice of liquid carrier that can be used. An alternative solution to this problem has been found. By adding just a small amount of liquid (2) to the particles (1), a flowable mixture is formed of a creamy or paste-like consistency. Providing too much liquid (2) is not present, the particles (1) do not separate out and so the choice of liquid carriers available for use in compositions of this type is greatly increased.
Patent AU-2006302559-B2 (AU)
Title: Modular flooring assemblies
Inventor: JONATHAN MCINTOSH
IPC: E04B2/08
Filed: 2006-10-03
Granted: 2011-12-08
Abstract: A modular flooring assembly 10 including a flooring component 600 adhered to a tray substrate 100 is described. The modular flooring assembly 10 may be interconnected with additional modular flooring assemblies to form a modular floor suitable for most flooring applications. The flooring component 600 may be tile or wood or other materials commonly used in flooring applications. Convention fill-in grout or a snap-in grout may be used with the modular flooring assemblies 10. One suitable snap-in grout is a right angle grout member 400. Another suitable snap-in grout is an interconnecting grout system 510.
Patent AU-2006327338-B2 (AU)
Title: Sizing of paper
Inventor: HANS JOHANSSON-VESTIN
IPC: D21H21/16
Filed: 2006-11-24
Granted: 2011-06-23
Abstract: The invention relates to an aqueous dispersion of cellulose-reactive sizing agent containing an acid anhydride, an anionic polyelectrolyte and a nitrogen-containing organic compound which is an amine or quaternary ammonium thereof having a molecular weight less than 180 and/or having one or more hydroxyl groups. The invention further relates to a method for the preparation of an aqueous dispersion of cellulose-reactive sizing agent which comprises dispersing an acid anhydride in an aqueous phase in the presence of an anionic polyelectrolyte and a nitrogen-containing organic compound which is an amine or quaternary ammonium thereof having a molecular weight less than 180 and/or having one or more hydroxyl groups. The invention also relates to the use of the aqueous dispersion of cellulose-reactive sizing agent as a stock sizing agent or surface sizing agent in the production of paper. The invention further relates to a process for the production of paper which comprises adding the aqueous dispersion of cellulose-reactive sizing agent to an aqueous cellulosic suspension.
Patent AU-2007202509-B2 (AU)
Title: Variable length coding method and variable length decoding method
Inventor: HAGAI MAKOTO
IPC: H04N19/70
Filed: 2007-05-31
Granted: 2009-12-10
Abstract: According to the present invention, an image coding apparatus provides a run-length encoding unit RLE1 that subjects quantized coefficients which are obtained by quantizing frequency components of an image signal to a variable length coding process by using a run value Run that indicates the number of successive zero coefficients and a level value Lev that indicates a value of a non-zero coefficient following the zero coefficients. The run-length encoding unit RLE1 includes an reordering unit Lreodr for reordering level values Lev; a variable length coder LVLC for coding reordered level values ROLev by using a code table that is selected according to the value of a quantization parameter QP; a reordering unit Rreodr for reordering run values Run from high frequency component of the quantized coefficients to low frequency component; and a variable length coder RVLC for coding reordered run values RORun by using a code table that is selected according to the number of already-processed run values. Accordingly, a variable length coding process for quantized coefficients is carried out at a higher coding efficiency, with redundant information included in the coefficients being effectively reduced.
Patent AU-2007332968-B2 (AU)
Title: Novel inhibitors of beta-lactamase
Inventor: VAISBURG ARKADII
IPC: A61K31/675
Filed: 2007-05-21
Granted: 2013-07-11
Abstract: This invention provides novel β-lactamase inhibitors of the aryl-and heteroarylsulfonarnidomethylphosphonate monoester class having nitrogen-based cations or quarternary ammomium groups. The compounds inhibit three classes of β-lactamases and synergize the antibacterial effects of β-lactam antibiotics (e.g., imipenem and ceftazimdime) against those micro-organisms normally resistant to the β-lactam antibiotics as a result of the presence of the β-lactamases. Formula (I) or pharmaceutically acceptable salt thereof.
Patent AU-2007334750-B2 (AU)
Title: Improved laundry appliance
Inventor: CHARLES RHODES DAVID
IPC: D06F37/04
Filed: 2007-12-20
Granted: 2011-12-01
Abstract: A laundry appliance having a perforated rotatable drum for spin dehydrating a wet textile load, an electric motor for providing an accelerating force which in use causes the drum to rotate, load sensors for detecting any static dynamic imbalance in the rotation of the drum, and a controller which receives inputs from the load sensors and is programmed to, in a spin-up phase, energise said electric motor so as to evenly distribute the load within the drum and thereby minimise any static or dynamic imbalance when the drum rotates.
Patent AU-2007352619-B2 (AU)
Title: Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds
Inventor: BOECKH ALBERT
IPC: A61K31/365
Filed: 2007-05-03
Granted: 2013-07-18
Abstract: Provided is a novel ivermectin derivative and compositions for the treatment or prophylaxis of parasite infestations in mammals or birds which comprise: (A) a pharmaceutically effective amount of a 1-N-phenylpyrazole compound; (B) a pharmaceutically effective amount of an ivermectin derivative of formula (II) wherein: R
Patent AU-2007357148-B2 (AU)
Title: Fluid pump with disposable component
Inventor: BUTTERFIELD ROBERT D
IPC: A61M5/142
Filed: 2007-09-06
Granted: 2014-01-09
Abstract: A pump having a disposable fluid contacting portion which defines a fluid inlet and outlet and a fluid path there between is presented. The pump includes a drive portion configured to engage the disposable portion to cause fluid to be moved from the fluid inlet to the fluid outlet. The disposable portion is configured to be selectively coupled to the drive portion. The disposable portion includes a driven membrane which forms a portion of the fluid path, and the drive portion includes a drive membrane. The two membranes are vacuum coupled to each other, whereby movement of the drive membrane causes the driven membrane to move, causing fluid to be pumped through the disposable portion. The pump has particular utility in the medical field for moving fluid from a source to a patient. The pump may include features such as an air-trap, bubble detection, fluid flow controls, and pressure detection.
Patent AU-2008203914-B2 (AU)
Title: An animal training device using a vibration probe to deliver a vibration stimulus to an animal
Inventor: MAININI CHRISTOPHER E
IPC: A01K15/02
Filed: 2008-01-02
Granted: 2011-11-17
Abstract: Described is a vibration stimulus delivery device for delivering a vibration stimulus to an animal by way of a vibration probe secured in physical contact with the skin of the animal. The vibration stimulus delivery device includes a vibration probe, a stimulus trigger detection device, and a carrying device. The vibration probe and the stimulus trigger detection device are secured to the carrying device, which is secured to the animal such that the animal carries the vibration probe and the stimulus trigger detection device. The vibration probe is disposed on the carrying device such that the vibration probe is secured in physical contact with the skin of the animal. The stimulus trigger detection device is adapted to detect an undesirable behavior and is in electrical communication with the vibration probe such that when the stimulus trigger detection device detects the undesirable behavior, the vibration probe is activated.
Patent AU-2008229782-B2 (AU)
Title: Seal for a fuel cell support
Inventor: ERIKSTRUP NIELS
IPC: H01M2/08
Filed: 2008-10-03
Granted: 2012-11-08
Abstract: A unit for use in a fuel cell stack, the unit comprising a porous metal support with a seal made by local fusion and 5 having a seal depth that extends from the upper surface of the porous metal support to at least the bottom surface of the porous metal support, and wherein the seal is posi tioned along the periphery of the porous metal support, the seal being impermeable to gas transported in the plane of 10 the porous metal support. 0) co 0) C) CN q 0 CD eu( 0o 0 CDID C CD D C 0 0)0 I (D D C C) I ID (D D C T-m M(DCDC 0)m
Patent AU-2008236691-B2 (AU)
Title: Integrated nucleic acid analysis
Inventor: BOGDANOV VALERY LEONIDOVICH
IPC: B01L3/00
Filed: 2008-04-04
Granted: 2014-08-07
Abstract: The present disclosure provides fully integrated microfluidic systems to perform nucleic acid analysis. These processes include sample collection, nucleic acid extraction and purification, amplification, sequencing, and separation and detection. The present disclosure also provides optical detection systems and methods for separation and detection of biological molecules. In particular, the various aspects of the invention enable the simultaneous separation and detection of a plurality of biological molecules, typically fluorescent dye-labeled nucleic acids, within one or a plurality of microfluidic chambers or channels. The nucleic acids can be labeled with at least 6 dyes, each having a unique peak emission wavelength. The present systems and methods are particularly useful for DNA fragment sizing applications such as human identification by genetic fingerprinting and DNA sequencing applications such as clinical diagnostics.
Patent AU-2008249191-B2 (AU)
Title: Drag-and-drop graphical control interface for algorithmic trading engine
Inventor: IAN DEMPSEY
IPC: G06F3/00
Filed: 2008-11-24
Granted: 2011-09-22
Abstract: Abstract of the Disclosure A graphical user interface is used along with an automated algorithm selection function to enable market participants to initiate automated, multi-algorithm 5 trading strategies through a single drag and drop motion. A symbol representing a security can be dragged and dropped onto an icon representing a tactical or strategic algorithm. Other features of the graphical user interface show information such as the progress of the algorithms. N:\MelbourneCaseo\Patent\29000-29999\P29420 AU 1\SpecS\P79420 AU 1 GH speci doc 24/11/08 Figure 6: Dropping symbol on desired participation rate to launch Fishbone for Participation Rate Algorithm A A B-C D E F-H H-K L M M-O P-5 5-T T-V ADI AMG BNE DGX E AY HTGC LEXR MEOX 55CC AEOS % RO 1 LPX MLNM 5AFC CCLE N KG LTXX MRVC OTTR SEAB Adp~ti eithmi Pipeln, Algoithi __~ Exectio , e.1irtn -*- , Socialite Reservist Spray Sloth 302 4 o 308 310
Patent AU-2008285528-B2 (AU)
Title: An electrosurgical instrument
Inventor: BOWLES MARK
IPC: A61B18/14
Filed: 2008-07-18
Granted: 2014-07-17
Abstract: An electrosurgical instrument for the treatment of tissue in the presence of an electrically-conductive fluid medium comprises an instrument shaft (10), and an electrode assembly (12) at one end of the shaft. The electrode assembly (12) comprises a tissue treatment electrode (14) and a return electrode (18) which is electrically insulated from the tissue treatment electrode by means of an insulation member (16). The tissue treatment electrode (14) has an exposed surface for treating tissue, and the return electrode (18) has a fluid contact surface so as to define, in use, a conductive fluid path that completes an electrical circuit between the tissue treatment electrode and the return electrode. The tissue treatment electrode (14) is provided with at least one aperture (14a) through which vapour bubbles and/or particulate material can be aspirated from the region surrounding the tissue treatment electrode, and the tissue treatment electrode and the insulation member are disposed such that there is a gap therebetween forming an additional suction channel (25).
Patent AU-2008308474-B2 (AU)
Title: Modular vascular graft for low profile percutaneous delivery
Inventor: WHIRLEY ROBERT G
IPC: A61F2/06
Filed: 2008-10-03
Granted: 2014-07-24
Abstract: A hybrid modular endovascular graft wherein a main graft is sized to span at least a portion of a target vessel lesion in a large percentage of patients. Graft extensions may be secured to the main graft to extend the main graft and provide a sealing function for some applications.
Patent AU-2009202595-B2 (AU)
Title: Process for reducing plume opacity
Inventor: SMYRNIOTIS CHRISTOPHER R
IPC: C10L9/10
Filed: 2009-06-26
Granted: 2011-06-23
Abstract: Plume is mitigated by targeting treatment chemicals to locations in a furnace, which are connected with plume opacity. The effectiveness of targeted in furnace injection, in fuel introduction and in furnace introduction of slag and/or corrosion and/or plume control chemicals are determined, as are the effectiveness of targeted in furnace injection, in fuel introduction and in furnace introduction of combustion catalysts. Then, the effectiveness of various combinations of the above treatments are determined, and a treatment regimen employing one or more of the above treatments is selected. Preferred treatment regimens will contain at least two and preferably three of the treatments. Chemical utilization and boiler maintenance can be improved as LOI carbon, slagging and/or corrosion are also controlled.